Workbook 7 Naumova
Pearson Conceptual Physics Workbook Answers. Design 7 soil mechanics,nature weekly journal science volume 217,nazi conspiracy aggression opinion. Navneet english grammar book for kids gujarati medium,naumova t v kuhnya. Comment3, Reshebnik po algebre 7 klass mordkovich. 4424, Gdz po angliiskomu starlight 5 workbook, 482. Reshebnik angliiskii iazyk 10 klass iukhnel naumova demchenko 2014, 851,.
LEADER 05929cam a2200517Ii 4500 001 120474 05110622.0 008 0 maua b 101 0 eng d 010 a z 035 a (OCoLC)ocm77548082 040 a OHX c OHX d YDXCP d VAM d BAKER d DLC d COU d KKP 016 7 a 971915830 2 GyFmDB 020 a (alk. Paper) 020 a 683 (alk. Paper) 020 a 081764542X (e-isbn) 020 a 427 (e-isbn) 029 0 a OHX b har040101368 029 1 a YDXCP b 2240989 035 a (OCoLC)77548082 072 7 a RA 2 lcco 082 0 0 a 610.78 2 22 096 a WA 950 b A2446 2004 049 a KKPA 245 0 0 a Advances in statistical methods for the health sciences: b applications to cancer and AIDS studies, genome sequence analysis, and survival analysis / c Jean-Louis Auget. [et al.], editors. 260 a Boston; Berlin: b Birkhäuser, c c2007. 300 a xl, 540 p.: b ill.; c 26 cm. 440 0 a Statistics for industry and technology 500 a Selected papers from the International Conference on Statistics in Health Sciences, held June 23-25, 2004 at Université de Nantes, Nantes, France--P.
504 a Includes bibliographical references and index. 505 0 a Systematic review of multiple studies of prognosis: the feasibility of obtaining individual patient data / D.G. [et al.] -- On statistical approaches for the multivariable analysis of prognostic marker studies / N. Holländer and W.
Sauerbrei -- Where next for evidence synthesis of prognostic marker studies? Improving the quality and reporting of primary studies to facilitate cinically relevant evidence-based results / R.D. [et al.] -- Sentinel event methods for monitoring unanticipated adverse events / P.A. Lachenbruch and J. Wittes -- Spontaneous reporting system modelling for the evaluation of automatic signal generation methods in pharmacovigilance / E. [et al.] -- Latent covariates in generalized linear models: a Rasch model approach / K.B.
Christensen -- Sequential analysis of quality of life measurements with the mixed partial credit model / V. Challa, and M. Mesbah -- A parametric degradation model used in reliability, survival analysis, and quality of life / M.
Gerville-Réache, and S. Orazio -- Agreement between two ratings with different ordinal scales / S. [et al.] -- The role of correlated frailty models in studies of human health, ageing, and longevity / A. [et al.] -- Prognostic factors and prediction of residual survival for hospitalized elderly patients / M.L. [et al.] -- New models and methods for survival analysis of experimental data / G.V. [et al.] -- Uniform consistency for conditional lifetime distribution estimators under random right-censorship / P.
Deheuvels and G. Derzko -- Sequential estimation for the semiparametric additive hazard model / L. Bordes and C. 
Breuils -- Variance-estimation of a survival function with doubly censored failure time data / C. Sun -- Statistical models and artificial neural networks: supervised classification and prediction via soft trees / A. Ciampi and Y. Lechevallier -- Multilevel clustering for large databases / Y. Lechevallier and A. Ciampi -- Neural networks: an application for predicting smear negative pulmonary tuberculosis / A.M.
[et al.] -- Assessing drug resistance in HIV infection using viral load using segmented regression H. Xiong -- Assessment of treatment effects on HIV pathogenesis under treatment by state space models / W.-Y. [et al.] -- Safety assessment versus efficacy assessment / M.A. Foulkes -- Cancer clinical trials with efficacy and toxicity endpoints: a simulation study to compare two nonparametric methods / A.
Letierce and P. Tubert-Bitter -- 505 0 a Safety assessment in pilot studies when zero events are observed / R.E. Carter and R.F. Woolson -- An assessment of up-and-down designs and associated estimators in phase I trials / H.K.T. Mohanty, and N. Balakrishnan -- Design of multicentre clinical trials with random enrolment / V.V.